The Deal
Wednesday, November 25, 
6:01 pm

Wal-Mart's earnings remedy

  Share     E-Mail    Discussion    Print Story

Wal-Mart StoreWho says America's No.1 retailer Wal-Mart dislikes health care? While it may not offer health care coverage for a majority of its employees, the giant discount juggernaut has no qualms about selling generic drugs. In fact, Wal-Mart has embraced prescription drugs as a means to increase revenue.

The Bentonville, Ark.-based retailer is introducing a $4 generic drug prescription program in 14 states that will include 1,264 stores: Alaska, Arizona, Arkansas, Delaware, Illinois, Indiana, Nevada, New Jersey, New Mexico, New York, North Carolina, Oregon, Texas and Vermont. The move follows a trial program that was launched in the retailer's 235 Florida Wal-Mart pharmacies on Oct. 6 that seems to have been a moderate success. Wal-Mart said it filled 88,235 new prescriptions in Florida in the 10 days after it rolled out the program.

Wal-Mart's program includes 314 generic prescriptions available for up to a 30-day supply at commonly prescribed dosages. Wal-Mart estimates that the list of $4 prescription medications represents nearly 25% of prescriptions that it currently fills in its pharmacies nationwide.

In a time when Americans are coping with an expensive and inefficient health care system, Wal-Mart looks to have hit a chord where there is tremendous demand. Already, Wal-Mart's competitors, Target and the Publix supermarket chain in Florida, have responded by lowering their prices on generic drugs in Florida in recent days.

Generic drugs are medicines no longer covered by a drug maker's exclusive patent, so they contain the same active ingredients, but are usually available at a substantial discount.

Wal-Mart hopes to expand its generic program nationwide by 2007. So, while most of Wal-Mart's employees — not to mention millions of other Americans — don't have health insurance, at least these people have an option to use their hard earned money to purchase generics from their employer. And that's a prescription that Wal-Mart certainly wouldn't mind filling... — Gerald Magpily

See story from MarketWatch
See story from CNN

Continue reading below

Also on Dealscape





Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: AlixPartners' Steve Deedy on Black Friday, the holiday season and retail bankruptcies.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

REIT IPO deja vu

Real estate sponsors that might wish to undertake an IPO will need to consider a wide variety of issues and begin to take action long before the first filing with the SEC.


Industry Insight

Loan-to-buy

Paulson's proposal to purchase an equity stake in Yellow Pages publisher Idearc is the second time in recent months an investor group has used its prepetition debt position to execute a bargain price 'exit LBO.'


Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.